Product Description: KRN5, a derivative of KRN2, is an oral active Nuclear factor of activated T cells 5 (NFAT5) suppressor, with an IC50 of 750 nM. KRN5 has potential to treat NFAT5-mediated Chronic Arthritis[1].
Applications: COVID-19-immunoregulation
Formula: C27H22FNO5
References: [1]Han EJ, et al. Suppression of NFAT5-mediated Inflammation and Chronic Arthritis by Novel κB-binding Inhibitors. EBioMedicine. 2017 Apr;18:261-273.
CAS Number: 1800465-47-7
Molecular Weight: 459.47
Compound Purity: 98.76
Research Area: Inflammation/Immunology
Solubility: DMSO : 5 mg/mL (ultrasonic;warming;heat to 80°C)
Target: Nuclear Factor of activated T Cells (NFAT)